David R. Mcavoy - Net Worth and Insider Trading
David R. Mcavoy Net Worth
The estimated net worth of David R. Mcavoy is at least $2,365 dollars as of 2024-12-27. David R. Mcavoy is the General Counsel and CCO of Fresh Tracks Therapeutics Inc and owns about 3,175 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $2,365. Details can be seen in David R. Mcavoy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R. Mcavoy has not made any transactions after 2021-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David R. Mcavoy
David R. Mcavoy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R. Mcavoy owns 2 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , and Endocyte Inc (ECYT) .
Click here to see the complete history of David R. Mcavoy’s form 4 insider trades.
Insider Ownership Summary of David R. Mcavoy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-07-23 | General Counsel and CCO |
| ECYT | Endocyte Inc | 2018-12-21 | General Counsel |
David R. Mcavoy Latest Holdings Summary
David R. Mcavoy currently owns a total of 1 stock. David R. Mcavoy owns 3,175 shares of Fresh Tracks Therapeutics Inc (FRTX) as of July 23, 2021, with a value of $2,365.
Latest Holdings of David R. Mcavoy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-07-23 | 3,175 | 0.75 | 2,365 |
Holding Weightings of David R. Mcavoy
David R. Mcavoy Form 4 Trading Tracker
According to the SEC Form 4 filings, David R. Mcavoy has made a total of 3 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 403 shares on July 23, 2021, which cost David R. Mcavoy around $12,143.
Insider Trading History of David R. Mcavoy
- 1
David R. Mcavoy Trading Performance
GuruFocus tracks the stock performance after each of David R. Mcavoy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R. Mcavoy is -19.54%. GuruFocus also compares David R. Mcavoy's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R. Mcavoy within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David R. Mcavoy's insider trading performs compared to the benchmark.
Performance of David R. Mcavoy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.77 | | | | | |
| Relative Return to S&P 500(%) | 4.13 | | | | | |
David R. Mcavoy Ownership Network
David R. Mcavoy Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
David R. Mcavoy is the General Counsel and CCO of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and Chief Financial Officer Marchio Albert N Ii .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, David R. Mcavoy made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
David R. Mcavoy Mailing Address
Above is the net worth, insider trading, and ownership report for David R. Mcavoy. You might contact David R. Mcavoy via mailing address: C/o Endocyte, Inc., 3000 Kent Avenue, Suite A1-100, West Lafayette In 47906.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
